Wegovy (semaglutide 2.4mg) retails for approximately $1,349 per month, making it one of the most expensive prescription medications many patients will ever encounter. But the sticker price is not what most people actually pay. Between manufacturer programs, insurance coverage, patient assistance, and other strategies, many patients get Wegovy for $0 to $25 per month.

Here is every legitimate path to getting Wegovy at little or no cost in 2026.

Option 1: [Wegovy Savings Card](/blog/wegovy-savings-card-coupon-2026) (Commercially Insured Patients)

This is the single most impactful cost-reduction tool for Wegovy, and most eligible patients do not realize how much it saves.

How It Works

Novo Nordisk offers the Wegovy Savings Card to commercially insured patients. When activated, the card reduces your out-of-pocket cost to as low as $0 per 28-day supply. The card covers the difference between your insurance copay/coinsurance and $0, up to a maximum benefit per fill.

Eligibility

  • You must have commercial (private) insurance that covers Wegovy
  • You must have a valid prescription from a licensed provider
  • Not eligible: Medicare, Medicaid, Tricare, VA, or other government-funded insurance

How to Activate

  1. Visit wegovy.com and navigate to the savings section
  2. Complete the eligibility questionnaire
  3. Receive your digital savings card
  4. Present it at the pharmacy along with your insurance card

What It Actually Saves

If your insurance covers Wegovy but leaves you with a $200 copay, the savings card covers that $200, bringing your cost to $0. The maximum benefit per fill is typically $500 to $600, which covers most commercial copay amounts.

Real-world impact: A patient with a $150 monthly copay saves $1,800 per year with the savings card. A patient with a $500 coinsurance obligation saves $6,000 per year.

Option 2: Novo Nordisk Patient Assistance Program (Uninsured/Underinsured)

If you do not have insurance or your insurance does not cover Wegovy, Novo Nordisk's Patient Assistance Program (PAP) may provide the medication at no cost.

Eligibility

  • Must be a U.S. resident
  • Must be uninsured or have insurance that does not cover Wegovy
  • Household income must be at or below 400% of the Federal Poverty Level (approximately $62,400 for an individual or $133,280 for a family of four in 2026)
  • Must have a valid prescription

How to Apply

  1. Download the application from novocare.com or call 1-888-809-3942
  2. Complete the application with your provider's help
  3. Submit income documentation (tax return, pay stubs, or benefit statement)
  4. If approved, Wegovy is shipped directly to your provider's office or your home at no charge

Processing Time

Applications typically take 2 to 4 weeks to process. Once approved, you are enrolled for 12 months and must reapply annually.

Option 3: Insurance Coverage + Appeal Strategies

Many insurance plans now cover Wegovy, but getting that coverage activated sometimes requires persistence.

Step 1: Check Your Formulary

Call the number on your insurance card or log into your plan's portal and search for Wegovy (semaglutide) on the formulary. Look for:

  • Tier placement (lower tier means lower copay)
  • Prior authorization requirements
  • Step therapy requirements (you may need to try other medications first)
  • Quantity limits

Step 2: Get Prior Authorization

Most insurers require prior authorization for Wegovy. Your prescribing provider will need to submit:

  • Your BMI (must be 30+ or 27+ with a weight-related comorbidity)
  • Documentation of weight-related health conditions (type 2 diabetes, hypertension, sleep apnea, etc.)
  • History of prior weight loss attempts (diet, exercise, other medications)
  • Clinical rationale for why Wegovy is medically necessary

Step 3: Appeal a Denial

If your prior authorization is denied, do not give up. Many denials are overturned on appeal.

First-level appeal: Your provider writes a letter of medical necessity with supporting documentation. Include clinical studies showing Wegovy's efficacy for your specific situation.

Peer-to-peer review: Request that your provider speak directly with the insurance company's medical director. This person-to-person conversation often resolves coverage disputes that paper appeals cannot.

External review: If internal appeals fail, most states allow you to request an independent external review by a third party. This is free and the decision is binding on the insurance company.

Success rates: Industry data suggests that approximately 40% to 60% of initial GLP-1 denials are overturned through the appeal process. The key is persistence and thorough documentation.

Option 4: Employer Benefits and Wellness Programs

Some employers offer enhanced prescription benefits or wellness programs that cover weight loss medications.

What to Check

  • Does your employer's plan explicitly cover anti-obesity medications? Many large employers have added GLP-1 coverage in recent years.
  • Does your company offer a wellness stipend? Some employers provide annual wellness dollars that can offset prescription costs.
  • Is there a weight management program benefit? Comprehensive programs sometimes include medication coverage as part of the benefit.

How to Advocate

If your employer's plan does not currently cover GLP-1 medications, contact your HR or benefits department. Employers are increasingly recognizing that covering weight loss medications reduces long-term healthcare costs. A polite, well-reasoned request can sometimes influence benefits decisions for the next plan year.

Option 5: Clinical Trials

Participating in a clinical trial can provide free Wegovy (or next-generation semaglutide formulations) along with comprehensive medical care at no cost.

How to Find Trials

  • ClinicalTrials.gov: Search for "semaglutide" and filter by your location, age, and condition
  • Novo Nordisk clinical trials: Check novomedlink.com for sponsored studies
  • Academic medical centers: Major research hospitals in your area often run weight loss medication trials

What to Expect

Clinical trial participants typically receive free medication for the duration of the study (often 6 to 18 months), regular medical monitoring, lab work, and clinical assessments at no cost. Some trials also offer compensation for time and travel.

The tradeoff: you may be randomized to a placebo group, and you must commit to regular study visits and follow the trial protocol strictly.

Option 6: State Pharmaceutical Assistance Programs

Several states operate pharmaceutical assistance programs that help residents afford expensive medications.

States with relevant programs include New York (EPIC), New Jersey (PAAD), Pennsylvania (PACE), and several others. Eligibility and coverage vary by state, but these programs can supplement federal options, particularly for patients who fall just above the income threshold for Novo Nordisk's PAP.

Search "[your state] pharmaceutical assistance program" to find your state's specific offerings.

The Step-by-Step Playbook

Here is the optimal order of operations to get Wegovy at the lowest possible cost:

  1. Check insurance formulary for Wegovy coverage
  2. If covered: Get prior authorization, then activate the Wegovy Savings Card for $0 copay
  3. If denied: File an appeal with documentation, request peer-to-peer review
  4. If uninsured or denied on all appeals: Apply for Novo Nordisk's Patient Assistance Program
  5. If income too high for PAP: Search for clinical trials on ClinicalTrials.gov
  6. If none of the above work: Consider compounded semaglutide ($149-$250/mo) as an affordable alternative

Bottom Line

Nobody should pay $1,349 per month for Wegovy without first exhausting every cost-reduction option. Between the savings card, patient assistance programs, insurance appeals, and clinical trials, most patients can find a path to free or dramatically reduced pricing. The process takes effort, but the savings are substantial.

Start with your insurance plan, use every appeal available to you, and layer on manufacturer savings programs. If the brand-name route is truly closed, compounded semaglutide from a reputable telehealth provider is a legitimate fallback that keeps treatment affordable.

Information reflects publicly available programs and policies as of early 2026. Eligibility criteria, savings card terms, and assistance program details change periodically. Always verify directly with Novo Nordisk and your insurance carrier.